Logo
B

Belyntic GmbH

3 employees

Novel paradigm-shifting vaccines with emphasis on cellular immunity

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Life Science
Platform technology
Cellular immunity
Health Care
Drug development

Date founded

2018

Funding rounds raised

Total raised

$1.4M

from 2 investors over 2 rounds

B

Belyntic GmbH raised $1.4M on September 17, 2019

Investors: High-Tech Gründerfonds and Investitionsbank Berlin

FAQ